Nita Khandelwal1, Catherine L Hough, Aasthaa Bansal, David L Veenstra, Miriam M Treggiari. 1. 1Department of Anesthesiology and Pain Medicine, University of Washington, Harborview Medical Center, Seattle, WA. 2Division of Pulmonary and Critical Care Medicine, University of Washington, Harborview Medical Center, Seattle, WA. 3Department of Biostatistics, University of Washington, Seattle, WA. 4Department of Pharmacy, University of Washington, Seattle, WA. 5Department of Epidemiology, University of Washington, Seattle, WA.
Abstract
OBJECTIVES: To describe long-term survival in patients with severe acute respiratory distress syndrome and assess differences in patient characteristics and outcomes among those who receive rescue therapies (prone position ventilation, inhaled nitric oxide, or inhaled epoprostenol) versus conventional treatment. DESIGN: Cohort study of patients with severe hypoxemia. SETTING: University-affiliated level 1 trauma center. PATIENTS: Patients diagnosed with severe acute respiratory distress syndrome within 72 hours of ICU admission between January 1, 2008, and December 31, 2011. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Data were abstracted from the medical record and included demographic and clinical variables, hospital and ICU length of stay, discharge disposition, and hospital costs. Patient-level data were linked to the Washington State Death Registry. Kaplan-Meier methods and Cox's proportional hazards models were used to estimate survival and hazard ratios. Four hundred twenty-eight patients meeting study inclusion criteria were identified; 62 (14%) were initiated on a rescue therapy. PaO2/FIO2 ratios were comparable at admission between patients treated with a rescue therapy and those treated conventionally but were substantially lower by 72 hours in those who received rescue therapies (54 ± 17 vs 69 ± 17 mm Hg; p < 0.01). For the entire cohort, estimated survival probability at 3 years was 55% (95% CI, 51-61%). Among 280 hospital survivors (65%), 3-year survival was 85% (95% CI, 80-89%). The relative hazard of in-hospital mortality was 68% higher among patients who received rescue therapy compared with patients treated conventionally (95% CI, 8-162%; p = 0.02). For long-term survival, the hazard ratio of death following ICU admission was 1.56 (95% CI, 1.02-2.37; p = 0.04), comparing rescue versus conventional treatment. CONCLUSIONS: Despite high hospital mortality, severe acute respiratory distress syndrome patients surviving to hospital discharge have relatively good long-term survival. Worsening hypoxemia was associated with initiation of rescue therapy. Patients on rescue therapy had higher in-hospital mortality; however, survivors to hospital discharge had long-term survival that was comparable to other acute respiratory distress syndrome survivors.
OBJECTIVES: To describe long-term survival in patients with severe acute respiratory distress syndrome and assess differences in patient characteristics and outcomes among those who receive rescue therapies (prone position ventilation, inhaled nitric oxide, or inhaled epoprostenol) versus conventional treatment. DESIGN: Cohort study of patients with severe hypoxemia. SETTING: University-affiliated level 1 trauma center. PATIENTS: Patients diagnosed with severe acute respiratory distress syndrome within 72 hours of ICU admission between January 1, 2008, and December 31, 2011. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Data were abstracted from the medical record and included demographic and clinical variables, hospital and ICU length of stay, discharge disposition, and hospital costs. Patient-level data were linked to the Washington State Death Registry. Kaplan-Meier methods and Cox's proportional hazards models were used to estimate survival and hazard ratios. Four hundred twenty-eight patients meeting study inclusion criteria were identified; 62 (14%) were initiated on a rescue therapy. PaO2/FIO2 ratios were comparable at admission between patients treated with a rescue therapy and those treated conventionally but were substantially lower by 72 hours in those who received rescue therapies (54 ± 17 vs 69 ± 17 mm Hg; p < 0.01). For the entire cohort, estimated survival probability at 3 years was 55% (95% CI, 51-61%). Among 280 hospital survivors (65%), 3-year survival was 85% (95% CI, 80-89%). The relative hazard of in-hospital mortality was 68% higher among patients who received rescue therapy compared with patients treated conventionally (95% CI, 8-162%; p = 0.02). For long-term survival, the hazard ratio of death following ICU admission was 1.56 (95% CI, 1.02-2.37; p = 0.04), comparing rescue versus conventional treatment. CONCLUSIONS: Despite high hospital mortality, severe acute respiratory distress syndrome patients surviving to hospital discharge have relatively good long-term survival. Worsening hypoxemia was associated with initiation of rescue therapy. Patients on rescue therapy had higher in-hospital mortality; however, survivors to hospital discharge had long-term survival that was comparable to other acute respiratory distress syndrome survivors.
Authors: L Gattinoni; G Tognoni; A Pesenti; P Taccone; D Mascheroni; V Labarta; R Malacrida; P Di Giulio; R Fumagalli; P Pelosi; L Brazzi; R Latini Journal: N Engl J Med Date: 2001-08-23 Impact factor: 91.245
Authors: Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: James W Davis; Deborah M Lemaster; Evan C Moore; Babak Eghbalieh; John F Bilello; Ricard N Townsend; Steven N Parks; Wade L Veneman Journal: J Trauma Date: 2007-05
Authors: Neill K J Adhikari; R Phillip Dellinger; Stefan Lundin; Didier Payen; Benoit Vallet; Herwig Gerlach; Kwang Joo Park; Sangeeta Mehta; Arthur S Slutsky; Jan O Friedrich Journal: Crit Care Med Date: 2014-02 Impact factor: 7.598
Authors: Claude Guerin; Sandrine Gaillard; Stephane Lemasson; Louis Ayzac; Raphaele Girard; Pascal Beuret; Bruno Palmier; Quoc Viet Le; Michel Sirodot; Sylvaine Rosselli; Vincent Cadiergue; Jean-Marie Sainty; Philippe Barbe; Emmanuel Combourieu; Daniel Debatty; Jean Rouffineau; Eric Ezingeard; Olivier Millet; Dominique Guelon; Luc Rodriguez; Olivier Martin; Anne Renault; Jean-Paul Sibille; Michel Kaidomar Journal: JAMA Date: 2004-11-17 Impact factor: 56.272
Authors: Frank Dodoo-Schittko; Susanne Brandstetter; Magdalena Brandl; Sebastian Blecha; Michael Quintel; Steffen Weber-Carstens; Stefan Kluge; Patrick Meybohm; Caroline Rolfes; Björn Ellger; Friedhelm Bach; Tobias Welte; Thomas Muders; Kathrin Thomann-Hackner; Thomas Bein; Christian Apfelbacher Journal: J Thorac Dis Date: 2017-03 Impact factor: 2.895
Authors: Harmke D Kiers; Gert-Jan Scheffer; Johannes G van der Hoeven; Holger K Eltzschig; Peter Pickkers; Matthijs Kox Journal: Anesthesiology Date: 2016-07 Impact factor: 7.892
Authors: Ruyang Zhang; Zhaoxi Wang; Paula Tejera; Angela J Frank; Yongyue Wei; Li Su; Zhaozhong Zhu; Yichen Guo; Feng Chen; Ednan K Bajwa; B Taylor Thompson; David C Christiani Journal: Intensive Care Med Date: 2016-12-28 Impact factor: 17.440
Authors: Ken Kuljit S Parhar; Karolina Zjadewicz; Andrea Soo; Alan Sutton; Margaret Zjadewicz; Lauren Doig; Calvin Lam; Andre Ferland; Daniel J Niven; Kirsten M Fiest; Henry T Stelfox; Christopher J Doig Journal: Ann Am Thorac Soc Date: 2019-10